Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

Achilles Therapeutics (ACHL) Institutional Ownership

$0.95
+0.03 (+3.57%)
(As of 05/17/2024 08:53 PM ET)

Institutional Ownership Changes (13F Filings) for Achilles Therapeutics (NASDAQ:ACHL)

Current
Institutional Ownership
Percentage
56.38%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$6.11M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$2.99M
Skip Chart & View Institutional Buying and Selling Data

ACHL Institutional Buying and Selling by Quarter

Achilles Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024 Artal Group S.A.755,375$944K0.0%-66.5%1.894%
5/17/2024 Ikarian Capital LLC1,443,181$1.80M0.2%N/A3.619%
5/15/2024 Baker BROS. Advisors LP1,208,775$1.51M0.0%-42.5%3.031%
5/14/2024 StemPoint Capital LP1,385,750$1.73M0.5%N/A3.475%
5/10/2024 Acadian Asset Management LLC280,929$350K0.0%N/A0.704%
3/7/2024 Fcpm Iii Services B.V.2,390,050$2.13M0.6%N/A5.861%
Next President (Not Trump. Not Biden.) (Ad)

Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.

Click here to see why it will be ______ _________.
2/14/2024 Vestal Point Capital LP108,083$96K0.0%N/A0.265%
5/12/2023 Forefront Analytics LLC75,625$72K0.0%+147.7%0.185%
2/14/2023 RA Capital Management L.P.1,607,834$1.45M0.0%-67.9%4.107%
11/14/2022 Point72 Asset Management L.P.2,107,595$4.76M0.0%+18.6%5.383%
11/14/2022 Forefront Analytics LLC32,200$72K0.0%N/A0.082%
8/15/2022 Point72 Asset Management L.P.1,776,744$4.48M0.0%+18.4%4.538%
8/15/2022 Kettle Hill Capital Management LLC242,978$612K0.2%N/A0.621%
2/15/2022 Sender Co & Partners Inc.27,690$139K0.1%N/A0.068%
2/14/2022 Point72 Asset Management L.P.1,000,000$5.01M0.0%+100.0%2.463%
2/11/2022 Syncona Portfolio Ltd11,086,909$55.55M53.1%N/A27.306%
11/15/2021 Point72 Asset Management L.P.500,000$3.90M0.0%N/A1.231%
11/15/2021 Sphera Funds Management LTD.242,500$1.89M0.2%-17.0%0.597%
11/15/2021 AXA S.A.279,454$2.18M0.0%+3.8%0.688%
11/15/2021Farallon Capital Management LLC450,000$3.51M0.0%-54.8%1.108%
11/12/2021 Affinity Asset Advisors LLC100,000$779K0.2%+25.0%0.246%
8/17/2021 Woodline Partners LP77,386$758K0.0%-67.6%0.191%
8/17/2021 Sphera Funds Management LTD.292,194$2.86M0.2%-2.6%0.719%
8/17/2021 Millennium Management LLC196,144$1.92M0.0%-3.3%0.483%
8/16/2021 RA Capital Management L.P.5,014,687$49.09M0.8%+261.1%12.345%
8/16/2021Pinz Capital Management LP16,423$161K0.0%+164.8%0.040%
8/16/2021 Macquarie Group Ltd.40,402$396K0.0%-26.9%0.099%
8/13/2021 Affinity Asset Advisors LLC80,000$783K0.3%+220.0%0.197%
8/13/2021 AXA S.A.269,135$2.64M0.0%N/A0.663%
8/12/2021 JPMorgan Chase & Co.49,405$484K0.0%-92.1%0.122%
8/12/2021 Monashee Investment Management LLC64,697$633K0.1%-48.2%0.159%
8/6/2021 Sei Investments Co.16,220$159K0.0%N/A0.040%
8/3/2021 Peregrine Capital Management LLC225,669$2.21M0.0%-30.0%0.556%
6/10/2021 Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860%
5/19/2021 Squarepoint Ops LLC28,000$463K0.0%N/A0.069%
5/18/2021 Baker BROS. Advisors LP2,591,366$42.89M0.2%N/A6.379%
5/18/2021 Millennium Management LLC202,785$3.36M0.0%N/A0.499%
5/18/2021 RA Capital Management L.P.1,388,888$22.99M0.3%N/A3.419%
5/18/2021 Orbimed Advisors LLC1,584,845$26.23M0.2%N/A3.901%
5/18/2021 Redmile Group LLC2,088,089$34.56M0.5%N/A5.140%
Next President (Not Trump. Not Biden.) (Ad)

Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.

Click here to see why it will be ______ _________.
5/18/2021 Alyeska Investment Group L.P.32,230$533K0.0%N/A0.079%
5/18/2021 Boxer Capital LLC1,536,208$25.42M0.9%N/A3.782%
5/18/2021 Citadel Advisors LLC39,253$650K0.0%N/A0.097%
5/17/2021 Deerfield Management Company L.P. Series C800,000$13.24M0.3%N/A1.969%
5/17/2021 Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860%
5/17/2021 Woodline Partners LP238,822$3.95M0.1%N/A0.588%
5/17/2021 Caas Capital Management LP50,000$828K0.0%N/A0.123%
5/17/2021Pinz Capital Management LP6,203$103K0.0%N/A0.015%
5/17/2021 Sphera Funds Management LTD.300,000$4.97M0.4%N/A0.739%
5/14/2021 Monashee Investment Management LLC125,000$2.07M0.3%N/A0.308%
5/12/2021 Pura Vida Investments LLC103,026$1.71M0.0%N/A0.254%
5/12/2021 JPMorgan Chase & Co.625,750$10.36M0.0%N/A1.540%
5/11/2021 Peregrine Capital Management LLC322,261$5.33M0.1%N/A0.793%
5/11/2021 Landscape Capital Management L.L.C.12,540$208K0.0%N/A0.031%
5/7/2021 BlackRock Inc.25,000$413K0.0%N/A0.062%
(Data available from 1/1/2016 forward)

ACHL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ACHL shares?

During the previous two years, 11 institutional investors and hedge funds held shares of Achilles Therapeutics. The most heavily invested institutionals were Point72 Asset Management L.P. ($4.76M), Fcpm Iii Services B.V. ($2.13M), Ikarian Capital LLC ($1.80M), StemPoint Capital LP ($1.73M), Baker BROS. Advisors LP ($1.51M), RA Capital Management L.P. ($1.45M), and Artal Group S.A. ($944K).Learn more on ACHL's institutional investors.

What percentage of Achilles Therapeutics stock is owned by institutional investors?

56.38% of Achilles Therapeutics stock is owned by institutional investors. Learn more on ACHL's institutional investor holdings.

Which institutional investors have been buying Achilles Therapeutics stock?

The following institutional investors have purchased Achilles Therapeutics stock in the last 24 months: Fcpm Iii Services B.V. ($2.39M), Ikarian Capital LLC ($1.44M), StemPoint Capital LP ($1.39M), Point72 Asset Management L.P. ($607.60K), Acadian Asset Management LLC ($280.93K), Kettle Hill Capital Management LLC ($242.98K), and Vestal Point Capital LP ($108.08K).

How much institutional buying is happening at Achilles Therapeutics?

Institutional investors have bought a total of 6,535,866 shares in the last 24 months. This purchase volume represents approximately $8.28M in transactions.

Which Achilles Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Achilles Therapeutics stock in the last 24 months: RA Capital Management L.P. ($3.41M), Artal Group S.A. ($1.50M), and Baker BROS. Advisors LP ($894.02K).

How much institutional selling is happening at Achilles Therapeutics?

Institutional investors have sold a total of 5,800,870 shares in the last 24 months. This volume of shares sold represents approximately $6.06M in transactions.


This page (NASDAQ:ACHL) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners